AGP Executive Report
Last update: 6 hours agoMedical Cannabis Industry Partnerships: Cannatrol’s Cool Cure Limited Edition program adds Operation Green Healing as its exclusive veterans nonprofit partner, with proceeds funding veteran wellness and alternative education. Clinical Research & Trial Design: A JAMA Psychiatry viewpoint argues psychedelic trials are hard to blind, since participants often can tell they’re on the active drug, which may skew results and make therapies look stronger than real-world use. Policy & Access: A bipartisan Congressional psychedelics caucus report calls for safer, more ethical integration of psilocybin and other psychedelics into U.S. healthcare, stressing coordination across federal agencies and states. Cannabis Use & Health: Multiple reports highlight cannabis-linked seizure burden and higher violence risk findings, adding to the growing debate over real-world risks versus therapeutic potential. Criminal Justice & Regulation: Virginia’s Clean Slate Act begins automatic sealing of certain conviction records, aiming to reduce long-term barriers for hundreds of thousands. Public Safety (Cannabis Exposure): A UK teen was hospitalized after allegedly smoking “spiked” cannabis, renewing warnings for parents and caregivers. State/Local Cannabis Retail: A Minnesota dispensary expansion story shows hemp-to-adult-use crossover as Spark MN opens in Mille Lacs County.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.